Uniplan Investment Counsel, Inc. Akoya Biosciences, Inc. Transaction History

Uniplan Investment Counsel, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$4.33 - $6.06 $113,939 - $159,462	26,314 Added 3.91%	699,837 $3.28 Million
Q4 2023 Feb 14, 2024	BUY	$3.13 - $5.13 $372,354 - $610,280	118,963 Added 21.45%	673,523 $3.42 Million
Q3 2023 Nov 14, 2023	BUY	$4.24 - $7.44 $48,098 - $84,399	11,344 Added 2.09%	554,560 $2.58 Million
Q2 2023 Aug 14, 2023	BUY	$5.28 - $8.35 $411,903 - $651,400	78,012 Added 16.77%	543,216 $4.01 Million
Q1 2023 May 15, 2023	BUY	$7.6 - $12.68 $492,844 - $822,272	64,848 Added 16.2%	465,204 $3.81 Million
Q4 2022 Feb 14, 2023	BUY	$8.6 - $14.1 $2 Million - $3.28 Million	232,647 Added 138.72%	400,356 $3.83 Million
Q3 2022 Nov 14, 2022	BUY	$10.63 - $15.76 $1.78 Million - $2.64 Million	167,709 New	167,709 $1.97 Million

12M

24.1K

Ticker AKYA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,892,300
Market Cap $107M
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...

Get notified when there are updates to the investment portfolio of Uniplan Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Uniplan Investment Counsel, Inc. with notifications on news.